Life Sciences Alternative Funding - Web3 Crypto Company Profile, Funding, Valuation, Investors - Cointime

Bitcoin $114,522.10 -0.76%
Ethereum $4,113.83 -1.31%
BNB $1,135.32 -1.36%
Optimism $0.45 -1.44%
Arbitrum $0.33 -2.67%
Solana $200.15 +0.01%
Polygon $0.22 +2.77%
Cosmos $3.17 -1.57%
Avalanche $20.23 -1.66%

Bitcoin $114,522.10 -0.76%
Ethereum $4,113.83 -1.31%
BNB $1,135.32 -1.36%
Optimism $0.45 -1.44%
Arbitrum $0.33 -2.67%
Solana $200.15 +0.01%
Polygon $0.22 +2.77%
Cosmos $3.17 -1.57%
Avalanche $20.23 -1.66%

Life Sciences Alternative Funding

investment firm

Summary
Investments
Exits
Employees

About

Life Sciences Alternative Funding provides capital to commercial-stage life sciences companies.

White Plains,New York,United States
http://www.lsafunding.com

Highlights

Lead Investments

Employee Profiles

Details

Operating Status: Active
Investor Type: Venture Debt

Investments

Number of Investments

Number of Lead Investments

4

1

Life Sciences Alternative Funding has made 4 investments. Their most recent investment was on May 12, 2015, when Harrow Health raised $15M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
May 12, 2015 Harrow Health	Post-IPO Debt	$15M	Biotechnology	—
Mar 10, 2015 Veniti	Debt Financing	—	Biotechnology	Yes
Apr 29, 2014 Integrated Diagnostics	Debt Financing	$17M	Biotechnology	—
Sep 17, 2013 VisionCare Ophthalmic Technologies	Debt Financing	$15M	Health Care	—

Employee Profiles

Number of Employee Profiles

1

Life Sciences Alternative Funding has 1 current employee profiles, including Executive Steve DeNelsky

Executive

Exits

Life Sciences Alternative Funding has had 3 exits. Life Sciences Alternative Funding most notable exits include Veniti , Integrated Diagnostics

Date	Company Name	Exit Type	Industry
Aug 8, 2018	Veniti	M&A	Biotechnology	Detail
Jul 9, 2018	Integrated Diagnostics	M&A	Biotechnology	Detail
Apr 30, 2007	Harrow Health	IPO	Biotechnology	Detail